Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial
The Lancet Neurology2016Vol. 15(8), pp. 801–810
Citations Over TimeTop 1% of 2016 papers
Rafael de la Torre, Susana Solá, Gimena Hernández, Magı́ Farré, Jesús Pujol, Joan Rodríguez, Josep M. Espadaler, Klaus Langohr, Aida Cuenca‐Royo, Alessandro Príncipe, Laura Xicota, Nathalie Janel, Silvina Catuara‐Solarz, Gonzalo Sánchez‐Benavides, Henri Bléhaut, Iván Dueñas-Espín, Laura del Hoyo Soriano, Bessy Benejam, Laura Blanco‐Hinojo, Sebastián Videla, Montserrat Fitó, Jean Maurice Delabar, Mara Dierssen
Related Papers
- Current and future applications of SPECT in clinical psychiatry.(1992)
- [Discontinuation of chronic treatment with lithium salts].(1992)
- Types Research of Discontinuation of a Crime(2007)
- → Accurate collection of reasons for treatment discontinuation to better define estimands in clinical trials(2022)